Polymorphism in the nuclear excision repair gene ERCC2/XPD: Association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma

Human Mutation

Volumn 25, Issue 4, 2005, Pages 353-359

  Lovatt, Tracy ^a   Alldersea, Julie ^a   Lear, John T ^b   Hoban, Paul R ^a   Ramachandran, Sudarshan ^a   Fryer, Anthony A ^a   Smith, Andrew G ^c   Strange, Richard C ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Basal cell carcinoma; ERCC2; Haplotypes; SNP; XPD

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXCISION REPAIR; EXON; FAMILY HISTORY; FEMALE; GENE FREQUENCY; HAPLOTYPE; HEAD CANCER; HUMAN; MALE; NECK CANCER; PRIORITY JOURNAL; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

ADULT; AGED; CARCINOMA, BASAL CELL; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SKIN NEOPLASMS; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 17144420525     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20158     Document Type: Article

References (31)

1. Armstrong BK, Kricker A. 2001. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8-18.
2. Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. 1998. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110:880-884.
3. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA, Strange RC. 2004. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen 43:121-127.
4. Brennan P. 2002. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23:381-387.
5. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris C. 2001. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22:593-555.
6. Dybdahl M, Vogel U, Frentz G, Wallin H, Nexo BA. 1999. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 8:77-81.
7. Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530.
8. Grossman L, Wei Q. 1995. DNA repair and epidemiology of basal cell carcinoma. Clin Chem 41:1854-1863.
9. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farell M. 1996. Non-melanoma skin cancer and solar keratoses. 1. Methods and descriptive results of the South Wales skin cancer study. Br J Cancer 74:1302-1307.
10. Heagerty AHM, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L, Alldersea J, Strange RC. 1994. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous malignancy. Lancet 343:266-268.
11. Hemminki K, Xu G, Angelini S, Snellman E, Jansen CT, Lambert B, Hou SM. 2001. XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis 22: 1185-1188.
12. Hoban PR, Ramachandran S, Strange RC. 2002. Environment, phenotype and genetics: risk factors associated with BCC of the skin. Expert Rev Anticancer Ther 2:570-579.
13. Lear JT, Smith AG, Bowers B, Heagerty AH, Jones PW, Gilford J, Alldersea J, Strange RC, Fryer AA. 1997. Tumor site in cutaneous basal cell carcinoma: influence of glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes and their interactions. J Invest Dermatol 108: 519-522.
14. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. 2000. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21:551-555.
15. Luscombe CJ, Fryer AA, French ME, Liu S, Saxby MF, Jones PW, Strange RC. 2001. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358:641-642.
16. Marcil I, Stern RS. 2000. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. A critical review of the literature. Arch Dermatol 136:1524-1530.
17. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, Grossman L, Mohrenweiser H, Wei Q. 2002. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes Carcinogenesis 23:295-299.
18. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Griffiths CE, Jones PW, Strange RC. 2000. Basal cell carcinoma: tumor clustering is associated with increased accrual in high-risk subgroups. Cancer 89:1012-1018.
19. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Jones PW Strange RC. 2001a. Cutaneous basal cell carcinomas: Distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer 92:354-358.
20. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Hartland AJ, Whiteside JR, Jones PW, Strange RC. 2001b. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. Pharmacogenetics 11:247-254.
21. Ramachandran S, Fryer AA, Lovatt T, Smith A, Lear J, Jones PW, Strange RC. 2002. The rate of increase in the number of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation. Carcinogenesis 23: 2051-2054.
22. Scrivener Y, Grosshans E, Cribier B. 2002. Variations of basal cell carcinomas according to gender, location and histopathological subtype. Br J Dermatol 147:41-47.
23. Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L, Harris C. 2001. Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res 61:7430-7434.
24. Strange RC, Hoban P, Salim A. 2002. Skin cancer and exposure to sunlight, polycyclic aromatic hydrocarbons and arsenic. Clin Occup Environ Med 2:803-828.
25. Strange RC, El-Genidy N, Ramachandran S, Lovatt TJ, Fryer AA, Smith AG, Lear JT, Wong C, Jones PW, Ichii-Jones F, Hoban PR. 2004. Susceptibility to basal cell carcinoma: Associations with PTCH polymorphisms. Ann Hum Genet 68:536-545.
26. Vogel U, Hedayati M, Dybdahl M, Grossman L, Nexo BA. 2001. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 22:899-904.
27. Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
28. Wong C, Strange RC, Lear JT. 2003. Basal cell carcinoma. BMJ 327:794-798.
29. Wood RD, Mitchell M, Sgouros J, Lindahl T. 2001. Human DNA repair genes. Science 291:1284-1289.
30. Yin J, Rockenbauer E, Hedayati M, Jacobsen NR, Vogel U, Grossman L, Bolund L, Nexo BA. 2002. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 11:1449-1453.
31. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. 2002. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91.